CAPZA, announces the arrangement of a Unitranche for the refinancing of Primed Group to support its future growth.
 
Founded in 1946, Primed Group is a leading provider of high-quality medical consumables and gas sterilisation services based in Germany.
 
With more than 450 employees and in-house capabilities across the entire value chain, the Group is highly competitive and has deep expertise ranging from product development to distribution, ensuring efficiency and highest quality at every stage.
 
The product portfolio consists of certified consumables for critical applications with a focus on tracheotomy/laryngectomy, wound care, thoracic drainage, and suction systems. Based on a global reach, the products are sold to hospitals, home care providers, and distributors in more than 60 countries. In addition to its deep product offering, Primed Group is one of a few OEMs (Official Equipment Manufacturer) to also provide gas sterilisation services to other MedTech and pharmaceutical companies.
 
Through this transaction, CAPZA arranged a Unitranche for the refinancing of the Group, which aims to expand the existing product range, develop new proprietary products, and enable the company to pursue strategic growth opportunities, both organically and through targeted acquisitions. This includes reinforcing its position as a leading player in the MedTech sector and expanding geographically to increase its market presence globally.
 
“Primed Group stands out as a trusted partner for healthcare providers worldwide, thanks to its exceptional quality, consistent reliability, deep product portfolio, and fully integrated model. We are proud to support the company’s next stage of growth and its continued commitment to innovation and quality.” – Guillaume de Jongh, Managing Partner & Co-Head Private Debt at CAPZA